Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 985 to 986 of 986 entries
Sorted by: Best Match Show Resources per page
Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?.

Dementia and geriatric cognitive disorders extra

Bittner V, Ullrich G, Thormann M, Müller NG, Friederichs C, Amthauer H, Heinze HJ, Bittner DM.
PMID: 22545039
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):283-91. doi: 10.1159/000330470. Epub 2011 Sep 21.

Clinically, Alzheimer's disease (AD) is by far the most common cause of dementia. Criteria for the diagnosis of dementia with Lewy bodies (DLB) are highly specific but not at all sensitive, which is reflected by the higher number of...

Cite
Bittner V, Ullrich G, Thormann M, et al. Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?. Dement Geriatr Cogn Dis Extra. 2011;1(1):283-91doi: 10.1159/000330470.
Bittner, V., Ullrich, G., Thormann, M., Müller, N. G., Friederichs, C., Amthauer, H., Heinze, H. J., & Bittner, D. M. (2011). Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?. Dementia and geriatric cognitive disorders extra, 1(1), 283-91. https://doi.org/10.1159/000330470
Bittner, Verena, et al. "Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?." Dementia and geriatric cognitive disorders extra vol. 1,1 (2011): 283-91. doi: https://doi.org/10.1159/000330470
Bittner V, Ullrich G, Thormann M, Müller NG, Friederichs C, Amthauer H, Heinze HJ, Bittner DM. Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?. Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):283-91. doi: 10.1159/000330470. Epub 2011 Sep 21. PMID: 22545039; PMCID: PMC3235939.
Copy Download .nbib Format: NLM
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.

Journal of thrombosis and haemostasis : JTH

Bosch FTM, Mulder FI, Huisman MV, Zwicker JI, Di Nisio M, Carrier M, Segers A, Verhamme P, Middeldorp S, Weitz JI, Grosso MA, Duggal A, Büller HR, Wang TF, Garcia D, Kamphuisen PW, Raskob GE, van Es N.
PMID: 34455706
J Thromb Haemost. 2021 Dec;19(12):3008-3017. doi: 10.1111/jth.15516. Epub 2021 Sep 12.

BACKGROUND: In the Hokusai VTE Cancer study, the risk of major bleeding was 2.9% higher in the edoxaban group compared with the dalteparin group, mainly due to more gastrointestinal bleedings in patients with gastrointestinal cancer. The identification of risk...

Cite
Bosch FTM, Mulder FI, Huisman MV, et al. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. J Thromb Haemost. 2021;19(12):3008-3017doi: 10.1111/jth.15516.
Bosch, F. T. M., Mulder, F. I., Huisman, M. V., Zwicker, J. I., Di Nisio, M., Carrier, M., Segers, A., Verhamme, P., Middeldorp, S., Weitz, J. I., Grosso, M. A., Duggal, A., Büller, H. R., Wang, T. F., Garcia, D., Kamphuisen, P. W., Raskob, G. E., & van Es, N. (2021). Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. Journal of thrombosis and haemostasis : JTH, 19(12), 3008-3017. https://doi.org/10.1111/jth.15516
Bosch, Floris T M, et al. "Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban." Journal of thrombosis and haemostasis : JTH vol. 19,12 (2021): 3008-3017. doi: https://doi.org/10.1111/jth.15516
Bosch FTM, Mulder FI, Huisman MV, Zwicker JI, Di Nisio M, Carrier M, Segers A, Verhamme P, Middeldorp S, Weitz JI, Grosso MA, Duggal A, Büller HR, Wang TF, Garcia D, Kamphuisen PW, Raskob GE, van Es N. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. J Thromb Haemost. 2021 Dec;19(12):3008-3017. doi: 10.1111/jth.15516. Epub 2021 Sep 12. PMID: 34455706.
Copy Download .nbib Format: NLM
Showing 985 to 986 of 986 entries